Skip to content

Clinical trials

Completed Phase 3 Staphylococcal Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Staphylococcal Infections Phase: Phase 3 Status: Completed Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20043
20055
20074
20082
20111
20131
20181
20191
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nabi Biopharmaceuticals6
Cumberland Pharmaceuticals2
Forest Laboratories2
Aridis Pharmaceuticals, Inc.1
Basilea Pharmaceutica1
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Heinrich-Heine University, Duesseldorf1
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center1
Merck Sharp & Dohme LLC1
NeuTec Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Staphylococcal Infections22
Bacterial Infections4
Staphylococcal Skin Infections4
Surgical Wound Infection4
Cellulitis3
Infections3
Sepsis3
Abscess2
Bacteremia2
Gram-Positive Bacterial Infections2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.